The Latest Developments in Cloud Data Center Technology

As 5G cellular networks continue to grow and take hold of our cities, it’s easy to forget how far we’ve come from even a decade ago. However, cloud operators and those that work with cloud data centers are seeing these record-breaking transformations take place on a daily basis.

According to Nathan Tracy, Manager of Industry Standards for the Data and Devices Unit at TE Connectivity, “the number of connections that are made in the cloud are increasing much faster than the population.”

He noted that these connections are increasing at a 10% compound annual growth rate compared to the 6% compound growth rate for the number of users.

To learn more about the latest changes happening in cloud data centers all over the world, host Tyler Kern tapped Tracy for his insights.

“We’re directly involved in helping the cloud go faster and meet the evolving needs as our technology changes,” he said. “The demand on their capabilities is just going through the roof.”

Tracy also noticed that the types of connections are changing from those in years past, as well. With machine-to-machine connections growing to become a huge percentage of the demand today, he predicted that these connections will soon make up 50% of all the connections on the cloud.

However, this foray into uncharted territory brings a wealth of obstacles too.

As the demand for higher data rates increases, cloud operators must deal with challenges like lower data transfer rates, greater power consumption, and thermal issues.

“It’s a whole combination of things that we’re dealing with… and, at the same time, it’s a constant march to higher data rates,” Tracy revealed.

Subscribe to the Connected World podcast on Apple Podcasts and Spotify to learn more about the latest technology trends that are helping create a safer, sustainable and connected future.

Follow us on social media for the latest updates in B2B!

Twitter – @MarketScale
Facebook – facebook.com/marketscale
LinkedIn – linkedin.com/company/marketscale

Follow us on social media for the latest updates in B2B!

Image

Latest

vitro
Analyzing the Suppressive TME in In Vitro Based Assays
April 19, 2025

In the rapidly advancing field of cancer immunotherapy, accurately modeling the tumor microenvironment (TME) has become essential to improving the predictive power of preclinical drug testing. As immune-modulating therapies surge forward, with over 4,000 immune modulators in development globally, scientists are refining assay technologies that maintain the complexity of patient-specific tumor biology. In vitro platforms…

Read More
cancer
Targeting T Cells Within the Cancer Immunity Cycle
April 19, 2025

As cancer immunotherapy continues to reshape treatment landscapes, fine-tuning T-cell responses has become a critical frontier. Recent advances in 3D organoid models and high-content imaging are enabling scientists to closely mimic patient-specific tumor environments—unlocking insights into how T cells behave, respond, and falter under immune checkpoint blockade. With over 4,000 immune modulators in clinical…

Read More
cancer Immunity cycle
Advanced In Vitro Technologies to Investigate Therapeutic Impact on the Cancer Immunity Cycle
April 19, 2025

As immunotherapy revolutionizes cancer treatment, the need for physiologically relevant preclinical models becomes more urgent than ever. Despite the success of immune checkpoint inhibitors, a large majority of patients fail to achieve long-lasting responses, prompting researchers to explore more complex and predictive assays. The cancer immunity cycle, first described in 2013, remains a central framework…

Read More
resistance
Inside Oncology Drug Development: Overcoming Resistance with Science
April 19, 2025

In the last two decades, oncology has undergone a transformation with over 300 new cancer therapies approved by the FDA—many offering novel mechanisms of action. Despite these innovations, resistance to treatment remains a critical challenge, with cancer cells evolving or adapting to evade even the most advanced therapeutics. This issue is particularly pressing given that…

Read More